Navigation Links
Millennium in Medical News

Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments

CAPE TOWN, South Africa, July 21 /PRNewswire-USNewswire/ -- In an unprecedented and historic show of unity, advocates for all the health Millennium Development Goals (MDGs) have charged the leaders of G-8 countries with reneging on their commitments to health by chronicall...

Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group

WALTHAM, Mass., June 25 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, pharmacomechanical thrombectomy (PMT) procedure adoption will accelerate over the next five years due to growing physician interest in treating deep...

Broncus Technologies' Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group

WALTHAM, Mass., June 16 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rise in the US prevalence of emphysema is prompting device firms to develop endoscopic devices used to diagnose or treat the condition. Curre...

Industry Veteran Stephen Duvall Joins Millennium Management Team

CHICAGO, June 11 /PRNewswire/ -- Millennium Pharmacy Systems, a leading provider of pharmacy services to the long-term care industry, today announced that health care industry veteran Stephen Duvall has joined the company as Senior Vice President, Sales and Marketing. He is also responsible for h...

Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group

WALTHAM, Mass., June 10 /PRNewswire/ -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that despite the economic downturn, market growth in the European gastrointestinal (GI) videoscope segment will be fueled by increased colorectal cancer (C...

Although the Health Care Market is Recession-Resistant, It Is Not Recession-Immune, According to Millennium Research Group's Medtech Economic Quarterly Publication

WALTHAM, Mass., May 28 /PRNewswire/ -- According to Millennium Research Group's (MRG's) Q1 2009 issue of Medtech Economic Quarterly (EQ), the health care and medtech industry has long been considered a recession-resistant segment of the economy; while this may be true, however, it is not reces...

US Spinal Nonfusion Procedures Set to Increase Nearly Five Times From 2008 to 2013, According to Millennium Research Group

WALTHAM, Mass., March 25 /PRNewswire/ -- According to Millennium Research Group's (MRG's) new US Markets for Spinal Implants 2009 report, the US spinal nonfusion technology segment will see an increase in procedure volumes through 2013 largely at the expense of traditional spinal fusion. Nonf...

Thrombectomy Device Market to Approach $300 Million by 2013, According to Millennium Research Group

In the news release, Thrombectomy Device Market to Approach $900 Million by 2013, According to Millennium Research Group, issued Jan. 7 by Millennium Research Group over PR Newswire, we are advised by the company that the headline should read "Thrombectomy Device Market to Approach $300 Million by ...

Dana-Farber Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society

WHITE PLAINS, N.Y., Jan. 13 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) has awarded a $550,000 grant to Anthony Letai, M.D., Ph.D., Department of Medical Oncology at Dana-Farber Cancer Institute in Boston. Millennium: The Takeda Oncology Company of Cambridge, MA provided support to t...

New Millennium CyberKnife in Brandon - Grand Opening Celebration on January 21, 2009 - Media Invited

BRANDON, Fla., Jan. 12 /PRNewswire/ -- It is with great excitement and enthusiasm that Tampa Bay Radiation Oncology announces the grand opening of Tampa Bay's "second" CyberKnife treatment center and "the first" to be located in Brandon - New Millennium CyberKnife Center located at 621 Lumsden...
Millennium in Medical Technology

Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer

THOUSAND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited (TSE: 4052), today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination...

University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society

WHITE PLAINS, N.Y., July 7 /PRNewswire/ -- The Leukemia & Lymphoma Society has awarded a $550,000 grant to Jonathan Friedberg M.D., M.M.Sc., of the James P. Wilmot Cancer Center at the University of Rochester Medical Center. Millennium Pharmaceuticals, The Takeda Oncology Company, of Cambridge...

John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden

...minate AIDS in Africa. About John Legend's Show Me Campaign Grammy Award winner, John Legend founded the Show Me Campaign after visiting millennium Villages in Ghana and Tanzania. The non-profit's mission is to end poverty around the world through sustainable development at the individual, family ...

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled

...d VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of millennium Pharmaceuticals. Plavix is a registered trademark of sanofi-aventis. CONTACT: Jules Abraham Lippert/Heilshorn & Associates ...

Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013

...r extremity procedures in Europe , according to millennium Research Group WALTHAM, Mass., May 28 /PRNewswire/ -- According to millennium Research Group's (MRG's) European Markets for Per...mo Medical, W. L. Gore, and many more. About millennium Research Group ...

Pain Relief in Just One Visit with Genzyme's Synvisc-One

... market to nearly $1 billion by 2013, according to millennium Research Group WALTHAM, Mass., March 23 /PRNewswire/ -- According to millennium Research Group's (MRG's) US Markets for Orthopedi... series cover Europe and Asia Pacific. About millennium Research Group ...

Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use

...re Performed on AMI Patients in 2008, According to millennium Research Group WALTHAM, Mass., Feb. 18 /PRNewswire/ -- According to millennium Research Group's (MRG's) US Markets for Intervent...edical, Terumo Medical, and many more. About millennium Research Group ...

Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial

...is part of a co-development program between Amgen, millennium and Takeda. The recent DMC guidance recommen...imately two-thirds of the study population. Amgen, millennium and Takeda plan to follow this recommendation whic...rate website, http://www.takeda.com . About millennium Millennium: The Takeda Oncology Company, a lead...

Takeda Initiates Two Phase III Studies with Vedolizumab (MLN0002) in Patients with Inflammatory Bowel Disease

... Disease OSAKA, Japan, Jan. 22 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") announced today that its wholly-owned subsidiary, millennium Pharmaceuticals, Inc., has initiated two Phase III clinical trials for vedolizumab (MLN0002), an investigational compound for inflammatory bowel disea...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... About VELCADE VELCADE is co-developed by millennium Pharmaceuticals, Inc. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. millennium is responsible for commercialization of VELCADE in... vs 15%) and pruritus (10% vs 5%). About millennium Millennium: The Takeda Oncology Company, a le...
Millennium in Medical Products

10mm ENDOlap™ Millennium Laparoscopes

Description: ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....
Company:Cardinal Health, Inc.

Beehive Millennium - Long-term Epilepsy Monitoring

Description: Beehive Millennium, the newest entry in the Beehive product line, combines decades of experience in epilepsy monitoring with the technology of the 21st century. Beehive Millennium is a powerful Windows-based digital Video/EEG instrument, providing complete data acquisition, recording and review cap...
Company:Grass Technologies

Angio-Seal Millennium Platform

Description: The Angio-Seal vascular closure device quickly seals femoral artery punctures following catheterization procedures, allowing for early ambulation and hospital discharge. The device creates a mechanical seal by sandwiching the arteriotomy between a bio-absorbable anchor and collagen sponge, which di...
Company:St. Jude Medical, Inc.

Millennium M10 Concentrator

Description:...ncentrator on the market. Fewer parts, combined with greater reliability, help you to reduce expenditure on accessories and unnecessary inventory. The millennium M10 is designed to be the highest performing and most reliable oxygen machine available....
Company:Respironics, Inc.

Millennium™ Microsurgical System

Description:...fficiency. Programming options allow for virtually unlimited parameters of storage and surgeon-controlled mode switching. With its modular design, the millennium system integrates innovation for today and the future....
Company:Bausch & Lomb Storz

Millennium 2000 Microplate Shaker Incubator

Description:... The millennium 2000 is a unique microprocessor controlled shaking incubator that accommoda...on the LCD. The plates remain visible under the clear protective cover. The millennium 2000 can be pre-configured for deepwell microplates....
Company:Bellco Glass, Inc.

More>>

Millennium in Medical Dictionary

Neurological Diseases

.... Official website of the National Institutes of Health (NIH) ... Neurological Manifestations of AIDS. Neurosarcoidosis. Neuroscience at the New millennium ... ... to bring promising new treatments to those afflicted with neurological diseases . ... the neurological psychiatric disorders that are...
Millennium in Biological News

Agricultural research key to food security

... week. With nearly a billion people suffering from chronic hunger, global food security remains a major concern, despite being a key goal of the UN millennium Development Goals (MDGs). Extreme weather events due to climate change and the recent trend to convert croplands to biofuels both threaten to put even...

Policy transparency key to saving world's fisheries

...Mora. "Some of these initiatives include the United Nations Code of Conduct for Responsible Fisheries, the Convention on Biological Diversity, and the millennium Ecosystem Assessment. Although these initiatives have been endorsed by most governments, a global assessment on the extent to which these ideals are a...

Cost-effective measures could stop child pneumonia deaths

...l's Department of International Health. "Fully funding and implementing these interventions could bring us a big step closer towards reaching the U.N. millennium Development Goals." "The next step is to assess how donors and countries currently deliver these interventions and want to progress in the coming y...

Researchers find the earliest evidence of domesticated maize

... of early Holocene maize and squash domestication in the Central Balsas River Valley, Mexcio" and "Starch grain and phytolith evidence for early ninth millennium B.P. maize from the Central Balsas River Valley, Mexico" -- being published in the PNAS Early edition, March 24. According to Ranere, recent studie...

Fifth annual Templeton-Cambridge fellowships awarded to 10 noted journalists

...ector, The Faraday Institute for Science and Religion, University of Cambridge John D. Barrow, FRS, Professor of Mathematical Sciences and Director, millennium Mathematics Project, University of Cambridge Gillian Beer, DBE, Emeritus King Edward VII Professor of English Literature, University of Cambridge ...

Evidence of earliest known domestic horses found in Kazakhstan

...to show that domestic horses differed from wild horses from the same region, and to prove that horses were harnessed and possibly ridden in the fourth millennium B.C., in Kazakhstan. Researchers used a novel method of analyzing residue from fat-soluble lipids found on ancient Botai pottery to find traces of ...

What we don’t know still hurts us, environmental researchers warn

...lobal agenda for research funding in the years to come. A worldwide 2005 millennium Ecosystem Assessment enlisted hundreds of scientists to develop a view of e... "The conclusion that things are getting worse in general comes out of the millennium Ecosystem Assessment," he said. "Our job was to say 'OK, what science do we...

Major conference on food Dec. 1-2, 2008

...neral, World Agroforestry Centre (ICRAF) Hartmann, Director General, International Institute for Tropical Agriculture (IITA) Hans Herren, President, millennium Institute Monty Jones, Executive Secretary, Forum for Agricultural Research in Africa (FARA) Justin Lin, Chief Economist and Senior Vice President, ...

Childhood environmental health

...s that taking action to address all such issues will ultimately reduce the burden of disease affecting children globally and so contribute towards the millennium Development Goals (MDGs). ...

ICSU launches new program to understand the human impact on Earth's life-support systems

...trients, soil formation and retention) as well as cultural and recreational services (spiritual, aesthetic, educational and eco-tourism). In 2005, the millennium Ecosystem Assessment (MA) reported that, because of human actions, more than 60% of ecosystem services were degraded or being used unsustainably. ...
Millennium in Biological Technology

Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York

THOUSAND OAKS, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that it will hold its Business Review Meeting on Friday, Nov. 7, 2008 at the Millennium Broadway Hotel, 145 West 44th Street, New York City, beginning at 8 a.m. Eastern Time. Participating in the meeti...

Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales

BASKING RIDGE, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) today announced that Benjamin Custodio has joined the Company as Executive Vice President of International Sales and a member of the Board of Directors. Mr. Custodio has ove...

Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.

BASKING RIDGE, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) today named Mark C. Mirken its new Chief Executive Officer and Chairman of its Board of Directors. Mirken has...

Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC's Drug Discovery & Development of Innovative Therapeutics Conference

WESTBOROUGH, Mass. June 30 /PRNewswire/ -- Joseph B. Bolen, Ph.D., CSO of Millennium Pharmaceuticals, will chair the Focus on Cancer track IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics Conference and Exhibition taking place August 4-7 at the World Trade Center Bosto...

Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period

OSAKA, Japan, and CAMBRIDGE, Mass., May 9 /PRNewswire-FirstCall/ -- Takeda Pharmaceutical Company Limited, "Takeda", (TSE: 4502) and Millennium Pharmaceuticals, Inc., "Millennium" (Nasdaq: MLNM ) today announced the successful completion of Takeda's cash tender offer by its wholly-owned subsi...

Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion

- Acquisition Accelerates Takeda's Vision of Becoming a Global Leader in Oncology - OSAKA, Japan, and CAMBRIDGE, Mass., April 10 /PRNewswire-FirstCall/ -- Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Millennium Pharmaceuticals, Inc. (Nasdaq: ML...

Life Sciences Leader Joins Millennium Board of Directors

CAMBRIDGE, Mass., Oct. 4 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced the election of Jeffrey M. Leiden, M.D., Ph.D., to its Board of Directors. Dr. Leiden, a Managing Director at Clarus Ventures, a life sciences venture capital firm, has a distin...

Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation

CAMBRIDGE, Mass., Sept. 13 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced that its presentation at the Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference will be webcast live and may be accessed by visiting the Investors section of ...

Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation

CAMBRIDGE, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced that its presentation at the Thomas Weisel Partners 2007 Healthcare Conference will be webcast live and may be accessed by visiting the Investors section of the Company's websi...

Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City

...- Nektar Therapeutics (Nasdaq: NKTR ) is scheduled to present at the upcoming BMO Capital Markets 9th Annual Focus on Healthcare Conference at the millennium Broadway Hotel in New York City on Wednesday, August 5, 2009 at 1:45 p.m. Eastern time. The presentation will be accessible via a Webcast throu...
Millennium in Biological Products

Attoglow Western Blot Analysis Kit: Millennium Enhancer from BioChain

Description: Attoglow Western Blot Analysis Kit is an ultra-sensitive chemiluminescent Western blot analysis kit developed by Biochain. It detects protein at attogram (10 -18 g) or yoctomole (10 -24 M) levels. This kit consists of three parts: Millennium Enhancer, protein interaction system and detection syst...
Company:BioChain

Western Blot Enhancing Kit from BioChain

Description:... Attoglow Western Blot Enhancing Kit contains millennium Enhancer which can significantly boost Western blot signals, and is compatible with other enhancing mechanisms to achieve multiplied enhancing effects...
Company:BioChain
Millennium in Biological Definition

Biotechnology

..., ranked by 2003 sales, are: Amgen Genentech Serono Biogen Idec Chiron Genzyme MedImmune Gilead Sciences Cephalon millennium Pharmaceuticals Biotechnology in fiction Star Trek The Breen use starships with organic technology. The starship USS Voyager u...

Eugenics

... about a "new" eugenics Pro-eugenics websites Future Generations Eugenics Portal Creative Conscious Evolution: A Eugenics Directory millennium Eugenics Section Mankind Quarterly ...
Millennium in Biological Dictionary

Median

...western portions of present-day Iran. This area is known as Media . They entered this region with the first wave of Iranian tribes, in the late second millennium BC . By the 6th century BC, after having... Mean, Median , Mode, Range, a selection of ... Can you show me how to find the mean, median , mode,...
Other Tags
(Date:4/18/2014)... have been awarded two-year grants for their work on ... Of the 110 initial submissions to the new Novo ... four projects were funded, three of which are led ... Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, M.D., ... will use his $500,000 proof of principle grant to ...
(Date:4/18/2014)... available in French . ... practice and regenerative medicine. A team led by Ludwik ... Paris Tech) and Didier Letourneur from the Laboratoire Recherche ... just demonstrated that the principle of adhesion by aqueous ... repair soft-tissue organs and tissues. This easy-to-use gluing method ...
(Date:4/17/2014)... that could be used to provide relief from ... made the discovery when researching how pain occurs ... , Dr Marzia Malcangio said: "We have been ... our findings could help chemotherapy patients who suffer ... effect of some chemotherapy drugs (such as vincristine) ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... 2014) Doctors who treat patients with a ... can face an agonizing treatment decision. , The ... and help relieve shortness of breath. But some ... can cause potentially fatal complications following transplantation. , ... Dilling, medical director of Loyola University Medical Center,s ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
(Date:4/18/2014)... NC Seeds that sprout as soon as they,re planted ... need to be more careful. In the wild, a plant ... day would risk disaster. More than just an insurance policy ... that seed dormancy has long-term advantages too: Plants whose ... rise to more species, finds in a team of researchers ...
(Date:4/17/2014)... , Respiratory syncytial virus (RSV) is a ... life-threating illness in very young and elderly populations. ... enters host cells through the fusion protein RSV ... interfering peptides that prevent bundle formation limit RSV ... susceptible to degradation. In this issue of the ...
(Date:4/17/2014)... Gauthier and Professor Luca Razzari of the nergie ... large grants from the John R. Evans Leaders ... for the acquisition of state-of-the-art biotech and nanophotonics ... grants from the Ministre de l,Enseignement suprieur, de ... Technologie (MESRST). These new laboratories will help us ...
Breaking Biology News(10 mins):Plants with dormant seeds give rise to more species 2JCI online ahead of print table of contents for April 17, 2014 2JCI online ahead of print table of contents for April 17, 2014 3JCI online ahead of print table of contents for April 17, 2014 4JCI online ahead of print table of contents for April 17, 2014 5JCI online ahead of print table of contents for April 17, 2014 6New state-of-the-art biotech and nanotech equipment for INRS 2
Other Contents